CHETONI, PATRIZIA
 Distribuzione geografica
Continente #
NA - Nord America 14.451
AS - Asia 6.870
EU - Europa 6.740
SA - Sud America 811
AF - Africa 285
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 9
Totale 29.178
Nazione #
US - Stati Uniti d'America 14.010
IT - Italia 2.825
CN - Cina 2.376
SG - Singapore 1.783
HK - Hong Kong 1.248
SE - Svezia 964
BR - Brasile 701
DE - Germania 604
BG - Bulgaria 563
CA - Canada 400
UA - Ucraina 384
TR - Turchia 342
KR - Corea 335
VN - Vietnam 329
GB - Regno Unito 317
RU - Federazione Russa 278
FI - Finlandia 250
CH - Svizzera 166
IN - India 159
CI - Costa d'Avorio 119
FR - Francia 107
AT - Austria 58
JP - Giappone 56
NG - Nigeria 52
BE - Belgio 39
AR - Argentina 38
BD - Bangladesh 37
PL - Polonia 37
IQ - Iraq 33
ES - Italia 28
SN - Senegal 27
ID - Indonesia 26
NL - Olanda 25
PK - Pakistan 22
ZA - Sudafrica 22
CZ - Repubblica Ceca 21
MX - Messico 19
UZ - Uzbekistan 17
GR - Grecia 15
VE - Venezuela 14
MA - Marocco 13
AE - Emirati Arabi Uniti 12
CL - Cile 12
EC - Ecuador 12
IE - Irlanda 12
SA - Arabia Saudita 12
EG - Egitto 11
PE - Perù 11
BJ - Benin 10
CO - Colombia 10
DK - Danimarca 10
AU - Australia 9
NP - Nepal 9
TN - Tunisia 9
KE - Kenya 8
LT - Lituania 8
PH - Filippine 8
PT - Portogallo 8
IL - Israele 7
JO - Giordania 7
MY - Malesia 7
PY - Paraguay 7
EU - Europa 6
IR - Iran 6
AZ - Azerbaigian 5
JM - Giamaica 5
PA - Panama 5
TW - Taiwan 5
DZ - Algeria 4
LB - Libano 4
PS - Palestinian Territory 4
RO - Romania 4
RS - Serbia 4
HU - Ungheria 3
KG - Kirghizistan 3
MN - Mongolia 3
NZ - Nuova Zelanda 3
OM - Oman 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
AO - Angola 2
BN - Brunei Darussalam 2
BO - Bolivia 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GE - Georgia 2
LV - Lettonia 2
NI - Nicaragua 2
SC - Seychelles 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
XK - ???statistics.table.value.countryCode.XK??? 2
AP - ???statistics.table.value.countryCode.AP??? 1
BB - Barbados 1
BS - Bahamas 1
CM - Camerun 1
CR - Costa Rica 1
GA - Gabon 1
Totale 29.166
Città #
Woodbridge 1.523
Ann Arbor 1.391
Ashburn 1.299
Hong Kong 1.234
Singapore 1.107
Chandler 1.053
Fairfield 873
Houston 865
Santa Clara 828
Serra 694
Milan 631
Dallas 609
Sofia 563
Jacksonville 505
Beijing 495
Shanghai 402
Ottawa 363
New York 362
Hefei 360
Wilmington 340
Cambridge 334
Seattle 334
Seoul 318
Boardman 248
Princeton 248
Nanjing 235
Izmir 223
Lawrence 218
Medford 182
Los Angeles 177
Des Moines 175
Bern 162
Lucca 123
Abidjan 119
Dong Ket 118
Grafing 111
Dearborn 102
Istanbul 98
Buffalo 82
Redondo Beach 77
Jüchen 76
Redwood City 71
Pisa 69
Nanchang 68
Rome 67
Council Bluffs 66
Munich 62
Kunming 54
São Paulo 53
The Dalles 52
Lagos 51
San Diego 51
Vienna 50
London 49
Columbus 48
Frankfurt am Main 45
Lancaster 42
Pontedera 42
Ho Chi Minh City 41
Livorno 41
Tokyo 41
Boulder 40
Hebei 38
Shenyang 38
Bremen 37
Changsha 36
Ogden 36
Pune 35
Tianjin 35
Falls Church 34
Warsaw 34
Brussels 33
Norwalk 28
Dakar 26
Marseille 26
Alessandria 25
Belo Horizonte 25
Florence 24
Guangzhou 24
Rio de Janeiro 24
Auburn Hills 23
Jakarta 22
Turku 22
Chicago 19
Hanoi 19
Hangzhou 18
Fuzhou 17
Phoenix 17
Jiaxing 16
Orange 16
Viareggio 16
Washington 16
Brno 15
Changchun 15
Chennai 15
Jinan 14
Montreal 14
San Jose 13
Ufa 13
Verona 13
Totale 21.251
Nome #
Development and validation of high-performance liquid chromatography method to quantify tavaborole during in vitro transungual permeation studies 260
A water-soluble, mucoadhesive quaternary ammonium chitosan-methyl-β-cyclodextrin conjugate forming inclusion complexes with dexamethasone 246
Liposomes as a potential ocular delivery system of distamycin A 221
Hydrogels for ocular delivery of pilocarpine: Preliminary evaluation in rabbits of the influence of viscosity and of drug solubility 216
Ionic liquids as potential enhancers for transdermal drug delivery 212
POLYMERIC OPHTHALMIC DRUG DELIVERY SYSTEMS: PREPARATION AND EVALUATION OF PILOCARPINE-CONTAINING INSERTS 206
Controlled release of timolol maleate from coated ophthalmic mini-tablets prepared by compression 202
Arabinogalactan as active compound in the management of corneal wounds: In vitro toxicity and in vivo investigations on rabbits 200
Ciclopirox Hydroxypropyl Chitosan (CPX‐HPCH) Nail Lacquer and Breathable Cosmetic Nail Polish: In Vitro Evaluation of Drug Transungual Permeation Following the Combined Application 196
Ophthalmic delivery systems based on drug-polymer-polymer ionic ternary interaction: in vitro and in vivo characterization 192
Application of the compression technique to the manifacture of pilocarpina ophthalmic inserts 190
PLGA microspheres for the ocular delivery of a peptide drug, vancomycin using emulsification/spray-drying as the preparation method: in vitro/in vivo studies 189
Tyrosol-enriched tomatoes by diffusion across the fruit peel from a chitosan coating: a proposal of functional food 189
In vitro transungual permeation of ciclopirox from a hydroxypropyl chitosan-based, water-soluble nail lacquer 184
Evaluation of pilocarpine-loaded albumin particles as controlled drug delivery systems for the eye. II. Co-administration with bioadhesive and viscous polymers 182
Aloe vera as ophthalmic drug delivery: preliminary evaluation 181
Preparation and evaluation in vitro of colloidal lipospheres containing pilocarpine as ion pair 179
Intraocular pressure reduction and systemic absorption of timolol after administration of one side-coated inserts in rabbits 178
Skin permeation and distribution of two sunscreens: a comparison between reconstituted human skin and hairless rat skin 178
Albuterol prodrugs for ocular administration: Synthesis and evaluation of the physico-chemical and IOP-depressant properties of three albuterol triesters 177
4-Methylbenzylidene camphor microspheres: Reconstituted epidermis (Skinethic®) permeation and distribution 176
Solid lipid nanoparticles as promising tool for intraocular tobramycin delivery: Pharmacokinetic studies on rabbits 176
Preparation and evaluation in vitro of solutions and o/w microemulsions containing levobunolol as ion-pair 175
Gel-forming erodible inserts for ocular controlled delivery of ofloxacin 172
Validation of bovine hoof slices as a model for infected human toenails: in vitro ciclopirox transungual permeation 172
Arabinogalactan: a new ophthalmic vehicle for dry eye protection and treatment of corneal lesions 170
pH-responsive nanostructures based on surface active fatty acid-protic ionic liquids for imiquimod delivery in skin cancer topical therapy 169
Hot-melt extrusion technique (HME) to develop intravitreal inserts 168
Optimization of skin permeation and distribution of ibuprofen by using nanostructures (coagels) based on alkyl vitamin C derivatives 167
Prolonged, contemporaneous administration of pilocarpine and timolol increases the aqueous humor pilocarpine levels in rabbits 166
Effect of 5-oxo-2-pyrrolidinecarboxylic acid (PCA) as a new topically applied agent for dry eye syndrome treatment 166
Rufloxacin eyedrops: effect of different formulations on ocular pharmacokinetics in rabbits 165
Healing of rabbits' cornea following laser welding: effect of solid and semisolid formulations containing indocyanine green 165
Arabinogalattano per uso oculare: caratterizzazione ed efficacia nel processo di riepitelizzazione corneale. 164
Ophthalmic composition containing mucoadhesive polysaccharides able to promote corneal re-epithelization 164
A collaborative evaluation of the cytotoxicity of two surfactants by using the human corneal epithelial cell line and the WST-1 test 164
Niaouli oils from different sources: analysis and influence on cutaneous permeation of estradiol in vitro 164
Inserts for sustained ocular delivery of pilocarpine: evaluation of a series of partial esters of (maleic acid-alkyl vinyl ether) alternating copolymers 162
Poloxamer 407 microspheres for orotransmucosal drug delivery. Part II: In vitro/in vivo evaluation 162
Evaluation of high- and low-molecular weight fractions of sodium hyaluronate and an ionic complex as adjuvants for topical ophthalmic vehicles containing pilocarpine 162
Ciclopirox vs amorolfine: in vitro penetration into and permeation through human healthy nails of commercial nail lacquers 162
Topical Formulations Containing Finasteride. Part II: Determination of Finasteride Penetration into Hair Follicles using the Differential Stripping Technique 161
Development of a Simple Dry Eye Model in the Albino Rabbit and Evaluation of Some Tear Substitutes 160
null 160
Nanostructured Drug Delivery Systems for Targeting 5-alpha-Reductase Inhibitors to the Hair Follicle 158
Ocular mini-tablets for controlled release of timolol. Evaluation in rabbits 158
Aqueous ophthalmic formulations containing formocortal solubilised by surfactants or complexing agents 156
Cytotoxicity on rabbit corneal epithelial cell cultures of some polymers used as ophthalmic adjuvants 156
Permeation and distribution of ferulic acid and its a-cyclodextrin complex from different formulations in hairless rat skin 156
Nonpolymeric nanoassemblies for ocular administration of acyclovir: Pharmacokinetic evaluation in rabbits 156
Evaluation of ocular permeation enhancers: In vitro effects on corneal transport of four ß-blockers, and in vitro/in vivo toxic activity 155
Ocular toxicity of some corneal penetration enhancers evaluated by electrophysiology measurements on isolated rabbit corneas 155
Silicone rubber/hydrogel composite ophthalmic inserts: Preparation and preliminary in vitro/in vivo evaluation 151
Formulations based on natural ingredients for treatment of nail diseases 151
Mucoadhesive ophthalmic vehicles: evaluation of polymeric low-viscosity formulations 150
In vitro cutaneous permeation and distrubution of Uvinul MC80 in cosmetic formulations through hairless rat and reconstituted human skin 149
Liposome-encapsulated mitomycin-C for reduction of corneal healing rate and ocular toxicity. 149
Mucoadhesive liquid ophthalmic vehicles - Evaluation of macromolecular ionic complexes of pilocarpine 149
Evaluation of muco-adhesive properties and in vivo activity of ophthalmic vehicles based on hyaluronic acid 149
Characterization and in vitro evaluation of an (ipn)-hydrogel for transdermal delivery of diltiazem. 148
Relevance of polymer molecular weight to the in vitro/in vivo performances of ocular inserts based on poly(ethylene oxide) 148
In vitro evaluation of some parameters involved in mucoadhesion of aqueous polymeric dispersions 148
Arabinogalactan in the Re-Epithelization and Glycocalyx Restoration Process of Rabbit Damaged Corneas 147
Niaouli oil as enhancer for transdermal permeation of estradiol. Evaluation of gel formulations on hairless rats in vivo 147
Polymeric ophthalmic drug delivery systems. Preparation and evaluation of pilocarpine-containing inserts 147
Development and Characterization of a Novel Peptide-Loaded Antimicrobial Ocular Insert 147
Liposomes for ocular delivery of vancomicyn: preparation and in vivo evaluation 146
Opthalmic compositions containing mucoadhesive polysaccharides able to promote corneal re-epithelization 145
Aloe purificata: formulazioni oftalmiche 144
Ocular bioadhesive drug delivery systems 144
Comparison of Liposome-Encapsulated Acyclovir with Acyclovir Ointment: ocular pharmacokinetics in rabbits 144
Vehicle and enhancer effects on transdermal permeation of estradiol from gel formulations: evaluation in vitro 143
Ophthalmic composition containing N-acetyl-cysteine for the treatment of dry-eye syndrome, 143
Combination of nanomicellar technology and in situ gelling polymer as ocular drug delivery system (Odds) for cyclosporine-a 143
Freeze-dried matrices for ocular administration of bevacizumab: a comparison between subconjunctival and intravitreal administration in rabbits 143
HPCH-based nail lacquers: “ex vivo” study on permeation of three antimycotics through bovine hoof membranes 142
Pharmacokinetics and anti-inflammatory activity in rabbits of a novel indomethacin ophthalmic solution 142
Rilascio contollato della pilocarpina da matrici oftalmiche preparate per compressione 141
[Formulations containing complexes of ophthalmic drugs with tannic acid: "in vitro" and "in vivo" evaluation]. FT Formulazioni contenenti complessi di farmaci oftalmici con acido tannico: preparazione e valutazione "in vitro" e "in vivo". 141
Arabinogalactan (AG) in dry eye age-related: a new mucoadhesive and no-viscous ophthalmic vehicle with protective effect on corneal epithelium. Experimental studies. 141
Preliminary evaluation of a series of amphiphilic timolol prodrugs: possible evidence for transscleral absorption. 141
Preparati oftalmici a base di polisaccaridi mucoadesivi con capacità riepitelizzante della cornea 140
Ophthalmic composition containing N-acetyl-cysteine for the treatment of dry-eye syndrome 140
Comparison of the effect of ultrasound and of chemical enhancers on transdermal permeation of caffeine and morphine through hairless mouse skin in vitro 140
Evaluation in rabbits of a liposomal formulation for ocular delivery of acyclovir 139
Effect of different terpene-containing essential oils on permeation of estradiol through hairless mouse skin 139
Effect of Nail Lacquer Composition on In Vitro Transungueal Permeation of Ciclopirox 138
Pectin microspheres as ophthalmic carriers for piroxicam: evaluation in vitro and in vivo in albino rabbits 138
Carrageenan-gelatin mucoadhesive systems for ion-exchange based ophthalmic delivery: in vitro and preliminary in vivo studies 138
Pharmacokinetics and pressure lowering effect in rabbits of timolol in a xyloglucan vehicle 137
Albumin microspheres for ocular delivery of piroxicam 136
Cytotoxicity of potential ocular permeation enhancers evaluated on rabbit and human corneal epithelial cell lines 136
Terbinafine nail solutions for topical treatment of onychomycosis: Ex vivo study on penetration/retention through and into keratin membranes 136
Cytotoxicity evaluation of three phthalocyanine photosensitisers on human corneal epithelium cell cultures 135
Influence of drug release rate on systemic timolol absorption from polymeric ocular inserts in the pigmented rabbit 135
Nanostructured Strategies for Melanoma Treatment—Part II: Targeted Topical Delivery of Curcumin via Poloxamer-Based Thermosensitive Hydrogels 134
Iontophoresis and Surfactants Combination on in Vitro Transungual Permeation of Nystatin 133
Nanostructured Strategies for Melanoma Treatment—Part I: Design and Optimization of Curcumin-Loaded Micelles for Enhanced Anticancer Activity 132
Hydrosoluble medicated nail lacquers: in vitro drug permeation and corresponding antimycotic activity 130
null 130
Totale 16.029
Categoria #
all - tutte 79.318
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 79.318


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.262 0 0 0 0 0 109 119 166 329 118 95 326
2021/20222.317 54 202 31 138 426 341 51 96 108 42 104 724
2022/20232.914 349 307 182 281 387 452 58 227 519 9 114 29
2023/20242.308 361 338 301 176 364 341 50 45 37 33 48 214
2024/20256.379 67 275 95 346 596 661 422 445 565 855 765 1.287
2025/20263.529 403 953 831 414 674 254 0 0 0 0 0 0
Totale 29.679